UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

Seminars in arthritis and rheumatism, 2014-12, Vol.44 (3), p.253-263

2014

Volltextzugriff (PDF)

Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial

The Lancet (British edition), 2017-06, Vol.389 (10086), p.2304-2316

2017

Volltextzugriff (PDF)

The changing landscape of biosimilars in rheumatology

Annals of the Rheumatic Diseases, 2016-06, Vol.75 (6), p.974-982

2016

Volltextzugriff (PDF)

Ultrasound of the hand is sufficient to detect subclinical inflammation in rheumatoid arthritis remission: a post hoc longitudinal study

Arthritis research & therapy, 2017-10, Vol.19 (1), p.221-221, Article 221

2017

Volltextzugriff (PDF)

Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update

Annals of the rheumatic diseases, 2016-01, Vol.75 (1), p.16-22

2016

Volltextzugriff (PDF)

Obesity and osteoarthritis in knee, hip and/or hand: an epidemiological study in the general population with 10 years follow-up

BMC musculoskeletal disorders, 2008-10, Vol.9 (1), p.132-132, Article 132

2008

Volltextzugriff (PDF)

Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000–2010

Annals of the rheumatic diseases, 2015-02, Vol.74 (2), p.381-388

2015

Volltextzugriff (PDF)

Definition of treatment response in rheumatoid arthritis based on the simplified and the clinical disease activity index

Annals of the rheumatic diseases, 2012-07, Vol.71 (7), p.1190-1196

2012

Volltextzugriff (PDF)

One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout study

Arthritis research & therapy, 2022-04, Vol.24 (1), p.88-88, Article 88

2022

Volltextzugriff (PDF)

The role of biosimilars in the treatment of rheumatic diseases

Annals of the Rheumatic Diseases, 2013-03, Vol.72 (3), p.322-328

2013

Volltextzugriff (PDF)

Efficacy of high intensity exercise on disease activity and cardiovascular risk in active axial spondyloarthritis: a randomized controlled pilot study

PloS one, 2014-09, Vol.9 (9), p.e108688-e108688

2014

Volltextzugriff (PDF)

Predictors of Fatigue in Rheumatoid Arthritis Patients in Remission or in a Low Disease Activity State

Arthritis care & research (2010), 2016-07, Vol.68 (7), p.1043-1048

2016

Volltextzugriff (PDF)

Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes

Annals of the rheumatic diseases, 2018-10, Vol.77 (10), p.1421-1425

2018

Volltextzugriff (PDF)

Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort

Annals of the rheumatic diseases, 2012-05, Vol.71 (5), p.681-686

2012

Volltextzugriff (PDF)

Carotid plaque characteristics and disease activity in rheumatoid arthritis

Journal of rheumatology, 2013-04, Vol.40 (4), p.359-368

2013

Volltextzugriff (PDF)

The cost savings of biosimilars can help increase patient access and lift the financial burden of health care systems

Seminars in arthritis and rheumatism, 2022-02, Vol.52, p.151939-151939, Article 151939

2022

Volltextzugriff (PDF)

Report from the OMERACT Hand Osteoarthritis Working Group: Set of Core Domains and Preliminary Set of Instruments for Use in Clinical Trials and Observational Studies

Journal of rheumatology, 2015-11, Vol.42 (11), p.2190-2197

2015

Volltextzugriff (PDF)

MRI in early rheumatoid arthritis: synovitis and bone marrow oedema are independent predictors of subsequent radiographic progression

Annals of the rheumatic diseases, 2011-03, Vol.70 (3), p.428-433

2011

Volltextzugriff (PDF)

EULAR 75-year anniversary: commentaries on key ARD papers from 1947

Annals of the rheumatic diseases, 2022-06, Vol.81 (6), p.751-752

Kvien, Tore K

2022

Volltextzugriff (PDF)

Using observational study data as an external control group for a clinical trial: an empirical comparison of methods to account for longitudinal missing data

BMC medical research methodology, 2022-05, Vol.22 (1), p.152-152, Article 152

2022

Volltextzugriff (PDF)

EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteria

Annals of the rheumatic diseases, 2013-04, Vol.72 (4), p.479-481

2013

Volltextzugriff (PDF)

Cardiovascular disease risk profiles in inflammatory joint disease entities

Arthritis research & therapy, 2017-07, Vol.19 (1), p.153-153, Article 153

2017

Volltextzugriff (PDF)

Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trials

Annals of the rheumatic diseases, 2012-12, Vol.71 (12), p.1921-1923

2012

Volltextzugriff (PDF)

Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study)

Trials, 2020-01, Vol.21 (1), p.13-13, Article 13

2020

Volltextzugriff (PDF)

1 – 25 von 568

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(536)
Mit Volltextzugriff
(452)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(478)
Life Sciences & Biomedicine
(474)
Rheumatology
(441)
Humans
(402)
Female
(273)
Male
(264)
Rheumatoid Arthritis
(255)
Middle Aged
(254)
Adult
(187)
Aged
(183)
Biological And Medical Sciences
(145)
Medical Sciences
(145)
Diseases Of The Osteoarticular System
(132)
Patients
(122)
Arthritis, Rheumatoid - Drug Therapy
(120)
Severity Of Illness Index
(114)
Antirheumatic Agents - Therapeutic Use
(113)
Inflammatory Joint Diseases
(113)
Arthritis
(98)
Treatment Outcome
(92)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial

The changing landscape of biosimilars in rheumatology

Ultrasound of the hand is sufficient to detect subclinical inflammation in rheumatoid arthritis remission: a post hoc longitudinal study

Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update

Obesity and osteoarthritis in knee, hip and/or hand: an epidemiological study in the general population with 10 years follow-up

Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000–2010

Definition of treatment response in rheumatoid arthritis based on the simplified and the clinical disease activity index

One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout study

The role of biosimilars in the treatment of rheumatic diseases

Health economics in the field of osteoarthritis: An Expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

Efficacy of high intensity exercise on disease activity and cardiovascular risk in active axial spondyloarthritis: a randomized controlled pilot study

Predictors of Fatigue in Rheumatoid Arthritis Patients in Remission or in a Low Disease Activity State

Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes

Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort

Carotid plaque characteristics and disease activity in rheumatoid arthritis

The cost savings of biosimilars can help increase patient access and lift the financial burden of health care systems

Report from the OMERACT Hand Osteoarthritis Working Group: Set of Core Domains and Preliminary Set of Instruments for Use in Clinical Trials and Observational Studies

MRI in early rheumatoid arthritis: synovitis and bone marrow oedema are independent predictors of subsequent radiographic progression

EULAR 75-year anniversary: commentaries on key ARD papers from 1947

Using observational study data as an external control group for a clinical trial: an empirical comparison of methods to account for longitudinal missing data

EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteria

Cardiovascular disease risk profiles in inflammatory joint disease entities

Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trials

Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study)

Suchergebnisse filtern